GT Biopharma (GTBP) Stock Highlights

1.75 | -8.85%

2024-12-21 07:43:20

GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

Statistics

Range Today

1.72 2.09

Volume Today 86.2K

Range 1 Year

1.86 10.66

Volume 1 Year 90.25M

Range 3 Year

1.86 116.7

Volume 3 Year 93.47M

Range 10 Year

1.86 1428

Volume 10 Year 96.99M

Highlights

Market Capitalization 7.44M (micro)

Floating Shares 1.67M

Current Price 1.75

Price To Earnings -0.36

Price To Book 1.35

Earnings Per Share -8.34

Payout Ratio 0%

Performance

Latest -8.85%

1 Month -45.14%

3 Months -15.05%

6 Months -42.05%

1 Year -78.15%

3 Years -98.38%

5 Years -95.96%

10 Years -99.79%

Benchmarks

Market Capitalization

359 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

139 / 368

Free Cashflow

93 / 352

Performance 5 years

330 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.